CompletedNCT05633108
A Study Based on the French National Health Insurance Database in people with Psychotic Disorders
This study is completed in the United Kingdom. It focuses on Schizophrenia.
In United KingdomSchizophreniaOtherOver 18 Years
Study directory
Back to overviewMental health studies with practical context.
Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
CompletedNCT05841030
A Study in people with Major Depressive Disorder (MDD) With Anhedonia and Inadequate Response to Current Antidepressant Therapy Including a Selective Serotonin Reuptake Inhibitor (SSRI) or Serotonin Norepinephrine Reuptake Inhibitor (SNRI)
This study is completed in the United States, in France, in Canada, .... It focuses on depression.
In United KingdomDepressionOtherFrom 18 Years to 74 Years
CompletedNCT05550532
Aticaprant 10 Milligrams (mg) for Depression
This study is completed in the United States, in France, in Canada, .... It is testing Aticaprant 10 Milligrams (mg) for Depression.
In United KingdomDepressionOtherFrom 18 Years to 74 Years
TerminatedNCT05518149
Aticaprant in Adult and Elderly people with Major Depressive Disorder (MDD)
This study was terminated in the United States, in Australia, in France, .... It is testing aticaprant for depression.
In United KingdomDepressionOtherFrom 18 Years to 74 Years
CompletedNCT02006628
GWP42003 for schizophrenia
This study is completed in the United Kingdom, in Poland, and in Romania. It is testing GWP42003 for schizophrenia.
In United KingdomSchizophreniaOtherFrom 18 Years to 65 Years
CompletedNCT04085172
TAK-503 in Children and Teenagers With Attention Deficit Hyperactivity Disorder (ADHD)
This study is completed in the United States, in the United Kingdom, in Belgium, .... It is testing TAK-503 for ADHD.
In United KingdomADHDOtherFrom 6 Years to 17 Years
CompletedNCT02713282
Transition to the Paliperidone Palmitate 3-Month Formulation for schizophrenia
This study is completed in France, in the United Kingdom, in Croatia, .... It is testing Transition to the Paliperidone Palmitate 3-Month Formulation for schizophrenia.
In United KingdomSchizophreniaOtherFrom 18 Years to 50 Years
CompletedNCT05137704
A Study on the Use of Healthcare Resources and Costs of Attention Deficit Hyperactivity Disorder (ADHD) in Adults in England
This study is completed in the United Kingdom. It focuses on ADHD.
In United KingdomADHDOtherOver 18 Years
CompletedNCT05145413
KarXT for schizophrenia
This study is completed in the United States, in the United Kingdom, in Bulgaria, .... It is testing KarXT for schizophrenia.
In United KingdomSchizophreniaOtherFrom 18 Years to 65 Years
CompletedNCT05741710
Use of Methylone for PTSD
This study is completed in the United States, in the United Kingdom, and in Ireland. It is testing use of Methylone for PTSD.
In United KingdomPTSDDrugA study involving a medication or substance.From 18 Years to 65 Years
CompletedNCT00714688
Effectiveness of Effectiveness and Safety of Prolonged Release OROS Methylphenidate in ADHD
This study is completed in France, in the United Kingdom, in Switzerland, .... It is testing Effectiveness and Safety of Prolonged Release OROS Methylphenidate for ADHD.
In United KingdomADHDOtherFrom 18 Years to 65 Years
CompletedNCT04693351
Troriluzole for OCD
This study is completed in the United States, in Canada, in the United Kingdom, .... It is testing troriluzole for OCD.
In United KingdomOCDOtherFrom 18 Years to 65 Years
Public registry coverage is progressing
HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.